Update on the European CHMP review of the safety of somatropin-containing medicines (NeLM News Service, 20 May 2011)

23 May 2011

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has finished the first round of its review into the safety of medicines containing somatropin. While they address the concerns raised during this first round, they confirm that clinicians can continue to prescribe these medicines in the approved therapeutic indications and doses.

Full article

Update on the European CHMP review of the safety of somatropin-containing medicines (NeLM News Service, 20 May 2011)

Related Topics

Share this story

Top stories

Most read